by GlobeNewsWire | Sep 8, 2016 | Globe Newswire
SAN DIEGO, Sept. 08, 2016 (GLOBE NEWSWIRE) — Apricus Biosciences, Inc. (Nasdaq:APRI), a biopharmaceutical company advancing innovative medicines in urology and rheumatology, today announced that Argentina has granted Apricus’ commercialization partner, Ferring...
by GlobeNewsWire | Sep 7, 2016 | Canadian Stocks, Globe Newswire
BURNABY, British Columbia, Sept. 07, 2016 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical-stage biopharmaceutical company, today announced that it has commenced an underwritten public offering of its common shares pursuant to its existing...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
SOUTH SAN FRANCISCO, Calif., Sept. 07, 2016 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that it has filed a Certificate of Amendment to its Amended and Restated Certificate of Incorporation to effect a 1-for-6 reverse stock...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
— Company to Focus on Improved Factor VIIa and IX Programs to Provide Prophylactic Subcutaneous Therapy to Hemophilia Patients — — Reduction in Workforce will Reallocate Financial Resources from Research Programs and Associated Personnel to...
by GlobeNewsWire | Sep 7, 2016 | Globe Newswire
JUPITER, Fla., Sept. 07, 2016 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”) (OTCQX:DYAI), a global biotechnology company focused on the development and large scale manufacture of low cost, better performing biologic vaccines and drugs at flexible...